December 18: The Week in Cancer News
Researchers estimate that breast cancer surpassed lung cancer as the most commonly diagnosed cancer globally in 2020, and more news of the week from Cancer Today.
Progress Against Cancer
Researchers estimate that breast cancer surpassed lung cancer as the most commonly diagnosed cancer globally in 2020, and more news of the week from Cancer Today.
When creating anything new, one must ask the question, “will others use it?” A driving force behind the creation of AACR Project GENIE (Genomics Evidence Neoplasia Information Exchange) was to create an open access...
Esophageal adenocarcinoma increasingly found in adults under 50, study finds
The FDA has expanded the approval of a molecularly targeted therapeutic to treat certain pediatric and adult patients with medullary thyroid cancer. The U.S. Food and Drug Administration has approved pralsetinib (Gavreto) to treat certain adult and pediatric patients age...
Several options are available for the treatment of breast cancer, including local therapies such as surgery and radiation therapy, as well as systemic therapies such as chemotherapy, hormone therapy, targeted therapy, and immunotherapy. While...
The pandemic may make cancer clinical trials more patient-centric, and more news of the week from Cancer Today.
A study indicates that some breast cancer patients who receive mastectomy and reconstruction may be at risk of persistent drug use following surgery.
Study finds adherence to follow-up screening guidelines is low among people at high risk of developing lung cancer, and more news of the week from Cancer Today.
Study suggests that germline genetics may influence lung cancer risk in this patient population. Native American ancestry was associated with increased mutations in the EGFR gene in lung cancer patients from Latin American countries,...
Roughly 6 percent of men and women in the United States will be diagnosed with lung and bronchus cancer during their lifetime. While both the incidence and mortality rates have been steadily decreasing in...
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now